StockWatch
·

Jubilant Pharmova Ltd

BSE: 530019

P/L Snapshot

Q2 FY27 · standalone

vs Q1 FY27·vs Q2 FY26
Revenue
69.40
+3.3%+3.3%
Expenditure
59.10
+3.0%+0.7%
Net Profit
7.60
+4.1%+218.8%
OPM %
17.08%
-0.80pp-0.69pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
-35.3939.50114.40189.30264.19Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Price Chart
Reports

Radiopharma Scaling Into Margin Headwinds—Execution Risk on SPECT Recovery

CDMO · radiopharma · SPECT

Result previewQ2 FY2709 Nov 20263 minPharma & Healthcare

Jubilant commits CAD 94.5 million to double RUBY-FILL capacity; Canada funds a quarter of it

radiopharmaceuticals · capacity expansion · RUBY-FILL

Research09 Oct 20264 min

Jubilant Pharmova Q1 FY27: PAT Slumps 45% YoY to ₹56 Cr as SPECT Loss Hits Margins

pharma · cdmo · margin compression

ResultsQ1 FY2710 Aug 20263 minPharma & Healthcare
Latest

Corporate Events

Board MeetingJUBLPHARMA
2026
13Nov

Board Meeting

The meeting of the Board of Directors is scheduled to consid…

BSE Filing ↗
Board MeetingJUBLPHARMA
2026
5Nov

Board Meeting

The Finance Committee of the Company approved the allotment …

BSE Filing ↗
Board MeetingJUBLPHARMA
2026
12Oct

Board Meeting

The Board of Directors meeting is scheduled to consider and …

BSE Filing ↗
Board MeetingJUBLPHARMA
2026
26Aug

Board Meeting

The 48th AGM will be held to receive, consider and adopt fin…

BSE Filing ↗
Board MeetingJUBLPHARMA
2026
26Aug

Board Meeting

The 48th AGM will be held on August 26, 2026. The agenda in…

BSE Filing ↗
DividendJUBLPHARMA
2026
19Aug

₹5 / share

BSE Filing ↗
DividendJUBLPHARMA
2026
19Aug

₹5 / share

BSE Filing ↗
Board MeetingJUBLPHARMA
2026
7Aug

Board Meeting

The meeting of the Board of Directors of the Company is sche…

BSE Filing ↗
DividendJUBLPHARMA
2026
24Jul

₹5 / share

BSE Filing ↗
Board MeetingJUBLPHARMA
2026
22May

Board Meeting

The Board of Directors recommended payment of final dividend…

BSE Filing ↗
Board MeetingJUBLPHARMA
2024
25Oct

Board Meeting

Intimation Of Board Meeting

BSE Filing ↗
DividendJUBLPHARMA
2024
2Aug

₹5 / share

BSE Filing ↗
Board MeetingJUBLPHARMA
2024
19Jul

Board Meeting

Inter-alia consider and approve Unaudited Standalone and Con…

BSE Filing ↗
Board MeetingJUBLPHARMA
2024
29May

Board Meeting

Consider and approve Audited Standalone and Consolidated Fin…

BSE Filing ↗
Board MeetingJUBLPHARMA
2024
2Feb

Board Meeting

Consideration and approval of Board Meeting Intimation for u…

BSE Filing ↗
Board MeetingJUBLPHARMA
2023
27Oct

Board Meeting

Consider and approve Unaudited Standalone and Consolidated F…

BSE Filing ↗
DividendJUBLPHARMA
2023
10Aug

₹5 / share

BSE Filing ↗